All stock lists
Harrow, Inc. (NASDAQ:HROW)
US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
28.80+0.36 (+1.27%)
Insider Score
––Not scored
HROW Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
HROW Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 70.66 M | 44.20 M | 89.09 M | 71.64 M | 63.74 M | 47.83 M |
| Revenue Growth (YoY) | 10.85 % | -7.59 % | 33.31 % | 45.44 % | 30.25 % | 38.29 % |
| Cost of Revenue | 20.30 M | 17.16 M | 18.47 M | 17.71 M | 16.23 M | 15.52 M |
| Gross Profit | 50.36 M | 27.05 M | 70.62 M | 53.93 M | 47.51 M | 32.31 M |
| SG&A Expense | 53.30 M | 43.23 M | 43.31 M | 0.00 | 0.00 | 0.00 |
| R&D Expense | 8.07 M | 5.89 M | 3.27 M | 3.32 M | 2.87 M | 3.03 M |
| Operating Expenses | 61.37 M | 49.13 M | 46.58 M | 39.18 M | 36.10 M | 43.54 M |
| Operating Income | -11.01 M | -22.08 M | 24.04 M | 14.75 M | 11.41 M | -11.23 M |
| Pretax Income | -17.27 M | -27.58 M | 10.40 M | 1.02 M | 5.00 M | -17.78 M |
| Tax Provision | 0.00 | 25.00 K | 3.77 M | 0.00 | 0.00 | 0.00 |
| Net Income | -17.27 M | -27.60 M | 6.63 M | 1.02 M | 5.00 M | -17.78 M |
| EPS (Basic) | -0.46 | -0.74 | 0.18 | 0.03 | 0.14 | -0.50 |
| EPS (Diluted) | -0.46 | -0.74 | 0.18 | 0.03 | 0.13 | -0.50 |
| Shares Outstanding | 37.35 M | 37.23 M | 36.76 M | 37.15 M | 36.79 M | 35.83 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.